Literature DB >> 15534090

Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma.

Stefan Wöhrer1, Berthold Streubel, Rupert Bartsch, Andreas Chott, Markus Raderer.   

Abstract

PURPOSE: Mucosa-associated lymphoid tissue (MALT) lymphoma comprises 7% of all newly diagnosed non-Hodgkin's lymphomas and is therefore among the most common lymphoma entities. Monoclonal gammopathy due to production of a monoclonal immunoglobulin by lymphoma cells is a well-known phenomenon associated with various types of B-cell non-Hodgkin's lymphomas. The objective of the present study was to evaluate the incidence and clinical relevance of paraprotein (PP) production in patients with MALT lymphoma. EXPERIMENTAL
DESIGN: Fifty two patients were prospectively evaluated with regard to differentiation of the MALT lymphoma cells, t(11;18) translocation, monoclonal immunoglobulin production, Helicobacter pylori (HP) status, stage, treatment, and clinical outcome.
RESULTS: Nineteen of 52 MALT lymphoma patients (36%) had PP (8 IgMkappa, 6 IgGkappa, 4 IgMlambda, and 1 IgAkappa). The histologic feature of plasmacytic differentiation correlated significantly with the production of PP (P = 0.001). No correlation was found between PP and clinical stage, HP status, and t(11;18) status. PP was, however, negatively associated with response to eradication of HP in gastric MALT lymphoma, and PP levels declined significantly in patients responding to chemotherapy or radiation. Importantly, both immunofixation and serum electrophoresis have to be performed to detect low PP levels.
CONCLUSIONS: In conclusion, PP levels may probably be used as a potential prognostic tool for response to HP eradication, and serial measurements may also allow for noninvasive assessment of response to radiation or chemotherapy in patients with MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534090     DOI: 10.1158/1078-0432.CCR-04-0803

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

1.  Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.

Authors:  M Raderer; B Streubel; S Wöhrer; M Häfner; A Chott
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

2.  [Sjögren-associated MALT-type lymphoma of labial salivary glands: rare constellation with amyloidosis and IgM-paraproteinemia].

Authors:  M J Flaig; S Ihrler
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

3.  IgM monoclonal gammopathy in gastric MALToma.

Authors:  Zhineng J Yang; Gurprataap S Sandhu; Nidhi Aggarwal; Kenneth E Fasanella; Mounzer Agha
Journal:  J Gastrointest Cancer       Date:  2014-03

4.  A case of monoclonal gammopathy in extranodal marginal zone B-cell lymphoma of the small intestine.

Authors:  Do Yeun Kim; Yong-Seok Kim; Hee Jin Huh; Jong Sun Choi; Jeong Seok Yeo; Beom Seok Kwak; Seok Lae Chae
Journal:  Korean J Lab Med       Date:  2011-01

5.  Nodal involvement of extranodal marginal zone lymphoma with extreme plasmacytic differentiation (Mott cell formation) simulating plasma cell neoplasm and lymphoplasmacytic lymphoma.

Authors:  Yosep Chong; Chang Suk Kang; Woo Jin Oh; Tae-Jung Kim; Eun Jung Lee
Journal:  Blood Res       Date:  2014-12-23

6.  A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation.

Authors:  Yosuke Matsumoto; Tetsuya Masuda; Ayako Nishimura; Hideki Horie; Kenichi Harada; Mihoko Yoshida; Kazuho Shimura; Hiroto Kaneko; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2019-09-21       Impact factor: 2.490

7.  IgG4-producing lymphoma arising in a patient with IgG4-related disease.

Authors:  Takuro Igawa; Toshiaki Hayashi; Kazuya Ishiguro; Yumiko Maruyama; Mai Takeuchi; Katsuyoshi Takata; Tadashi Yoshino; Yasuharu Sato
Journal:  Med Mol Morphol       Date:  2016-04-11       Impact factor: 2.309

Review 8.  Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?

Authors:  Leonidas Alevizos; Ilias P Gomatos; Spyridon Smparounis; Manousos M Konstadoulakis; Georgios Zografos
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

9.  A phase II study of bortezomib in patients with MALT lymphoma.

Authors:  Marlene Troch; Constanze Jonak; Leonhard Müllauer; Andreas Püspök; Michael Formanek; Wolfgang Hauff; Christoph C Zielinski; Andreas Chott; Markus Raderer
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

10.  Erdheim-chester disease associated with marginal zone lymphoma and monoclonal proteinemia.

Authors:  Peter G Pavlidakey; Alok Mohanty; Lisa J Kohler; Howard J Meyerson
Journal:  Case Rep Hematol       Date:  2011-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.